 | | |
| Version 2013-2014 |
|
| PHIN2008-2 | Clinical viewpoints
- Metabolising medication and pharmacokinetic limits
- Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies)
- Information and adverse drug events monitoring
|
|
| Duration : | Metabolising medication and pharmacokinetic limits : 20h Th
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : 15h Th
Information and adverse drug events monitoring : 10h Th
|
|
| Number of credits : |
|
|
| Lecturer : | Metabolising medication and pharmacokinetic limits : Roger Verbeek
Theoretical and practical views on clinical studies (including the statistical methods applied to clinical studies) : André Scheen
Information and adverse drug events monitoring : Raphaël Denooz
|
|
| Coordinator : | Philippe Hubert |
|
Language(s) of instruction :
|
| French language |
|
Course contents :
|
|
 | | Information and adverse drug events monitoring |
|
| This course is dedicated to some notions of Information and Publicity in the field of therapeutic drugs. Pharmacovigilancy aspects are also approached. (Definition and imputability criteria of adverse drugs effects, CBPH operating, ...) |
|
|
Learning outcomes of the course :
|
|
| | Information and adverse drug events monitoring |
|
| Table of contents:
1. Pharmacovigilancy: Evaluation of the therapeutic risk
2. Pharmacovigilancy in Belgium and in Europe
3. Information and Publicity |
|
|
Prerequisites and co-requisites/ Recommended optional programme components :
|
|
| | Information and adverse drug events monitoring |
|
| Toxicology course of the second cycle |
|
|
Planned learning activities and teaching methods :
|
|
| | Information and adverse drug events monitoring |
|
| Pointless |
|
|
Mode of delivery (face-to-face ; distance-learning) :
|
|
| | Information and adverse drug events monitoring |
|
| 3 courses of 3 or 4 hours |
|
|
Recommended or required readings :
|
|
| | Information and adverse drug events monitoring |
|
| PowerPoint slides |
|
|
Assessment methods and criteria :
|
|
| | Information and adverse drug events monitoring |
|
| Written evalation in january |
|
|
Work placement(s) :
|
| |
|
Organizational remarks :
|
| |
|
Contacts :
|
|
| | Information and adverse drug events monitoring |
|
| Dr Raphaël DENOOZ
Clinical and Forensic Toxicological laboratory
CHU B35
Sart-Tilman, B4000 Liège
Tél.04/3667683
Fax 04/3668889
e-mail : Raphael.Denooz@chu.ulg.ac.be |
|
|
